Clinical Edge Journal Scan

Delayed diagnosis raises mortality risk for RA patients with lung disease


 

Key clinical point: Diagnostic delay was an independent predictor of mortality in RA patients with interstitial lung disease in a multivariate analysis.

Major finding: Diagnostic delay was significantly associated with increased risk of mortality in adults with RA and interstitial lung disease (hazard ratio 1.11), along with age, severe oxygen desaturation on effort (SatO2) and diffusion capacity for carbon monoxide (DLCO); with hazard ratios of 1.33, 0.85, and 0.62, respectively.

Study details: The data come from a multicenter study of 106 consecutive adults with rheumatoid arthritis and interstitial lung disease.

Disclosures: The study received no outside funding. The researchers had no financial conflicts to disclose.

Source: Cano-Jiménez E et al. Sci Rep. 2021 Apr 28. doi: 10.1038/s41598-021-88734-2.

Recommended Reading

Study shows how COVID-19 disrupted RA meds
MDedge Rheumatology
Boosting the presence of darker skin in rheumatology education
MDedge Rheumatology
Line of therapy matters for assessing biologic’s serious infection risk in RA
MDedge Rheumatology
Baricitinib continuation rate high in real-world practice
MDedge Rheumatology
Multiple studies highlight pandemic’s impact on patients with rheumatic disease
MDedge Rheumatology
Clinical Edge Commentary: RA May 2021
MDedge Rheumatology
JAK inhibitors may hinder DNA damage response
MDedge Rheumatology
Beta blocker use reduced remission in rheumatoid arthritis
MDedge Rheumatology
Internet intervention eases anxiety in rheumatoid arthritis patients
MDedge Rheumatology
Watch for rheumatic immune-related adverse events in ICI patients
MDedge Rheumatology